HIV-1 Nef-Src Family Kinase Interaction: A Novel Target for the Inhibition of HIV-1 Pathogenesis

作者: Purushottam Narute

DOI:

关键词:

摘要: Human immunodeficiency virus-1 (HIV-1) is a lentivirus responsible for development of AIDS. In addition to typical retroviral proteins (Gag, Pol and Env), primate lentiviruses like HIV-1 encode two regulatory (Tat Rev) four accessory (Vif, Vpu, Vpr Nef). The factor Nef essential high-titer viral replication AIDS progression. function requires interaction with many host cell proteins, including specific members the Src kinase family. this dissertation project, I explored whether Src-family (SFK) activation conserved property nef alleles from wide range primary isolates its sensitivity selective pharmacological inhibitors. Representative major subtypes A1, A2, B, C, F1, F2, G, H, J K strongly activated Hck Lyn as well c-Src lesser extent, demonstrating first time that SFK highly M-group isolates. Moreover, patient-derived also Hck. Recently, our group identified 4-amino diphenylfuranopyrimidines (DFPs) diphenylpyrazolyldiazene (PPD-B9) compounds selectively inhibit Nef-dependent HIV replication. To determine these novel exhibit broad-spectrum antiretroviral activity against HIV-1, constructed chimeric forms strain NL4-3 expressing same 10 alleles. infectivity chimeras was indistinguishable wild-type in three distinct lines (MT2, U87MG CEM-T4). Importantly, 4-aminopropanol 4-aminobutanol derivatives DFP PPD-B9 potently inhibited all both CEM-T4 cells manner. effects correlated inhibition endogenous SFKs. My results demonstrate Hck, by among clades targeting pathway uniformly inhibits have strong public health significance developing therapeutics current drug resistant variants HIV-1.

参考文章(243)
C. H. Lee, B. Leung, M. A. Lemmon, J. Zheng, D. Cowburn, J. Kuriyan, K. Saksela, A single amino acid in the SH3 domain of Hck determines its high affinity and specificity in binding to HIV-1 Nef protein The EMBO Journal. ,vol. 14, pp. 5006- 5015 ,(1995) , 10.1002/J.1460-2075.1995.TB00183.X
J. Skowronski, D. Parks, R. Mariani, Altered T cell activation and development in transgenic mice expressing the HIV-1 nef gene. The EMBO Journal. ,vol. 12, pp. 703- 713 ,(1993) , 10.1002/J.1460-2075.1993.TB05704.X
Elizabeth R. Wonderlich, Jolie A. Leonard, Kathleen L. Collins, HIV immune evasion disruption of antigen presentation by the HIV Nef protein. Advances in Virus Research. ,vol. 80, pp. 103- 127 ,(2011) , 10.1016/B978-0-12-385987-7.00005-1
Oliver T Fackler, Andreas S Baur, Live and Let Die: Nef Functions beyond HIV Replication Immunity. ,vol. 16, pp. 493- 497 ,(2002) , 10.1016/S1074-7613(02)00307-2
Frank Peter, HIV Nef: The Mother of All Evil? Immunity. ,vol. 9, pp. 433- 437 ,(1998) , 10.1016/S1074-7613(00)80626-3
Murray B. Gardner, Paul A. Luciw, Animal models of AIDS. The FASEB Journal. ,vol. 3, pp. 2593- 2606 ,(1989) , 10.1096/FASEBJ.3.14.2556312
S. Swingler, A. Mann, J.-M. Jacqué, B. Brichacek, V.G. Sasseville, K. Williams, A.A. Lackner, E.N. Janoff, R. Wang, D. Fisher, M. Stevenson, HIV-1 Nef mediates lymphocyte chemotaxis and activation by infected macrophages. Nature Medicine. ,vol. 5, pp. 997- 1003 ,(1999) , 10.1038/12433
Y. Collette, H. Dutartre, A. Benziane, F. Ramos-Morales, R. Benarous, M. Harris, D. Olive, Physical and Functional Interaction of Nef with Lck HIV-1 Nef-INDUCED T-CELL SIGNALING DEFECTS Journal of Biological Chemistry. ,vol. 271, pp. 6333- 6341 ,(1996) , 10.1074/JBC.271.11.6333